Marker Therapeutics, Inc. Contracts & Agreements

Form of Pre-Funded Warrant (Filed With SEC on December 23, 2024)

Form of Series A Warrant (Private Placement Warrant) (Filed With SEC on December 23, 2024)

Securities Purchase Agreement dated December 19, 2024 (Filed With SEC on December 23, 2024)

Registration Rights dated December 19, 2024 (Filed With SEC on December 23, 2024)

Securities Purchase Agreement dated December 19, 2024 (Filed With SEC on December 19, 2024)

Form of Common Stock Certificate of Marker Therapeutics, Inc (Filed With SEC on March 26, 2024)

Description of Securities of Marker Therapeutics, Inc (Filed With SEC on March 26, 2024)

Master Services Agreement for Product Supply between Marker Therapeutics, Inc. and Cell Ready LLC dated February 22, 2024 (Filed With SEC on March 26, 2024)

Work Order #1 between Marker Therapeutics, Inc. and Cell Ready LLC dated February 22, 2024 (Filed With SEC on March 26, 2024)

Separation Agreement between Marker Therapeutics, Inc. and Peter Hoang dated as of April 27, 2023 (Filed With SEC on May 15, 2023)

Purchase Agreement between Cell Ready, LLC and Marker Therapeutics, Inc., dated May 1, 2023 (Filed With SEC on May 15, 2023)

Purchase Agreement, dated as of December 12, 2022, by and between the Company and Lincoln Park (Filed With SEC on December 13, 2022)

Registration Rights Agreement, dated as of December 12, 2022, by and between the Company and Lincoln Park (Filed With SEC on December 13, 2022)

Marker Therapeutics, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on August 11, 2022)

RSU AWARD GRANT NOTICE (2020 EQUITY INCENTIVE PLAN) (Filed With SEC on May 13, 2022)

Services Agreement, effective April 12, 2022, between Wilson Wolf Manufacturing Corporation and Marker Therapeutics, Inc (Filed With SEC on April 26, 2022)

Underwriting Agreement, dated March 11, 2021 (Filed With SEC on March 16, 2021)

Form of Stock Option Grant Notice and Stock Option Agreement under the Marker Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on November 9, 2020)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Marker Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on November 9, 2020)

Description of Common Stock of Marker Therapeutics, Inc (Filed With SEC on March 12, 2020)

Registration Rights Agreement, dated February 28, 2020, between Marker Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on March 2, 2020)

Common Stock Purchase Agreement, dated February 28, 2020, between Marker Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on March 2, 2020)

Employment Agreement by and between Mythili Koneru and the Company dated February 6, 2019 (Filed With SEC on May 10, 2019)

Exclusive License Agreement between Baylor College of Medicine and Marker Therapeutics, Inc. dated March 16, 2018 (Filed With SEC on March 15, 2019)

Sponsored Research Contract between Baylor College of Medicine and Marker Therapeutics, Inc. dated November 16, 2018 (Filed With SEC on March 15, 2019)

Consulting Agreement between Dr. Ann Leen and Marker Therapeutics, Inc. dated October 19, 2018 (Filed With SEC on March 15, 2019)

Form of Director and Officer Indemnification Agreement (Filed With SEC on March 15, 2019)

Amendment to Employment Agreement between Marker Therapeutics, Inc. and Peter Hoang, dated March 14, 2019 (Filed With SEC on March 15, 2019)

Amendment to Employment Agreement between Marker Therapeutics, Inc. and Michael J. Loiacono dated as of November 27, 2018 (Filed With SEC on December 3, 2018)

Employment Agreement between Marker Therapeutics, Inc. and Anthony Kim dated as of November 27, 2018 (Filed With SEC on December 3, 2018)

Consulting Agreement between Dr. Juan Vera and Marker Therapeutics, Inc. dated October 19, 2018 (Filed With SEC on October 23, 2018)

Form of Stock Option Award Agreement-Consultant (Filed With SEC on October 23, 2018)

Form of Stock Option Award Agreement-Employee (Filed With SEC on October 23, 2018)

Amendment to the 2014 Omnibus Stock Ownership Plan, as amended through August 29, 2017 (Filed With SEC on October 17, 2018)

Board Observer and Director Nomination Agreement with New Enterprise Associates, Inc (Filed With SEC on October 17, 2018)

Form of Warrant (Filed With SEC on June 8, 2018)

Form of Securities Purchase Agreement (Filed With SEC on June 8, 2018)

Common Stock Purchase Agreement (Filed With SEC on May 15, 2018)

Warrant Exercise Agreement (Filed With SEC on May 15, 2018)

Form of Stock Certificate (Filed With SEC on March 23, 2018)

Form of Director and Officer Indemnification Agreement (Filed With SEC on March 23, 2018)

Employment Agreement between TapImmune Inc. and Peter Hoang dated as of September 22, 2017 (Filed With SEC on September 25, 2017)

Amendment to Employment Agreement between TapImmune Inc. and Glynn Wilson, dated as of September 22, 2017 (Filed With SEC on September 25, 2017)

2014 Omnibus Stock Ownership Plan, as amended through August 29, 2017 (Filed With SEC on September 5, 2017)

FIRST AMENDMENT (Filed With SEC on June 26, 2017)

INVESTOR WARRANT (Filed With SEC on June 22, 2017)

BROKER WARRANT (Filed With SEC on June 22, 2017)

SUBSCRIPTION AGREEMENT (Filed With SEC on June 22, 2017)

RegistrationRights Agreement (Filed With SEC on June 22, 2017)

WARRANT EXERCISE AGREEMENT (Filed With SEC on June 22, 2017)

KATALYST SECURITIES LLC 630 THIRD AVENUE, 5TH FLOOR NEW YORK, NY 10017 TEL: 212 ###-###-#### Member: FINRA & SIPC PLACEMENT AGENCY AGREEMENT (Filed With SEC on June 22, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on August 25, 2016)

CONFIDENTIAL TREATMENT REQUESTED BY TAPIMMUNE, INC. (Filed With SEC on August 15, 2016)

INVESTOR WARRANT (Filed With SEC on August 11, 2016)

TAPIMMUNE INC. SERIESA WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

TAPIMMUNE INC. SERIESC WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

TAPIMMUNE INC. SERIESD WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

TAPIMMUNE INC. SERIESE WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

TAPIMMUNE INC. SERIESA-1 WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

Form of Series D-1 Warrants TAPIMMUNE INC. SERIESD-1 WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

Form of Series E-1 Warrant TAPIMMUNE INC. SERIESE-1 WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

Form of Series F Warrant TAPIMMUNE INC. SERIESF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

Form of Series F-1 Warrant TAPIMMUNE INC. SERIESF-1 WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 11, 2016)

BROKER WARRANT (Filed With SEC on August 11, 2016)

SUBSCRIPTION AGREEMENT (Filed With SEC on August 11, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 11, 2016)

WARRANT AMENDMENT AGREEMENT (Filed With SEC on August 11, 2016)

KATALYST SECURITIES LLC 1330 AVENUE OF THE AMERICAS, 14TH FLOOR NEW YORK, NY 10019 TEL: 212 ###-###-#### Member: FINRA & SIPC GP NUREMENKARI INC. 18EAST 41ST STREET, SUITE 1902... (Filed With SEC on August 11, 2016)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on July 19, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on July 19, 2016)

AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on February 16, 2016)

SECOND AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on February 16, 2016)

TapImmune Inc. 2014 OMNIBUS STOCK OWNERSHIP PLAN THE PLAN (Filed With SEC on November 16, 2015)

AMENDMENT TO (Filed With SEC on November 16, 2015)

TapImmune Inc. 2014 Omnibus Stock Ownership Plan Stock Option Award Agreement (Filed With SEC on November 16, 2015)

TAPIMMUNE INC. 2014 OMNIBUS STOCK OWNERSHIP PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on November 16, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on November 16, 2015)

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH LICENSE AND ASSIGNMENT AGREEMENT (Filed With SEC on August 14, 2015)

CONSULTING AGREEMENT (Filed With SEC on July 30, 2015)

AMENDED AND RESTATED RESTRUCTURING AGREEMENT (Filed With SEC on June 5, 2015)

RESTRUCTURING AGREEMENT (Filed With SEC on June 3, 2015)

Form of Series A-1 Warrants TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 10, 2015)

Form of Series B-1 Warrants TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 10, 2015)

Form of Series C-1 Warrants TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 10, 2015)

Form of Series D-1 Warrants TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 10, 2015)

Form of Series E-1 Warrant TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 10, 2015)

Placement Agent Series A-1 Warrant (Filed With SEC on March 10, 2015)

Form of Placement Agent Series B-1 Warrant (Filed With SEC on March 10, 2015)

Form of Placement Agent Series C-1 Warrant (Filed With SEC on March 10, 2015)

Form of Placement Agent Series D-1 Warrant (Filed With SEC on March 10, 2015)

Form of Placement Agent Series E-1 Warrant (Filed With SEC on March 10, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 10, 2015)

[SIGNATURE PAGE TO EA AMENDMENT FOLLOWS] (Filed With SEC on March 10, 2015)

Form of Series A Warrants TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 12, 2015)

Form of Series B Warrants TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 12, 2015)

Form of Series C Warrants TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 12, 2015)

Form of Series D Warrants TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 12, 2015)

Form of Series E Warrant TAPIMMUNE INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 12, 2015)

Form of Placement Agent Series A Warrant (Filed With SEC on January 12, 2015)

Form of Placement Agent Series B Warrant (Filed With SEC on January 12, 2015)

Form of Placement Agent Series C Warrant (Filed With SEC on January 12, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 12, 2015)

OLYMPUS SECURITIES, LLC (Filed With SEC on January 12, 2015)

COMMON STOCK PURCHASE WARRANT TAPIMMUNE INC. (Filed With SEC on August 14, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 14, 2014)

OPTION AGREEMENT (Filed With SEC on April 15, 2014)

TapImmune Inc. Convertible Promissory Note (Filed With SEC on October 24, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 23, 2011)

COMMON STOCK PURCHASE WARRANT TAPIMMUNE INC. (Filed With SEC on November 23, 2011)

SECURED CONVERTIBLE NOTE Minimum U.S. $1,000,000.00 Maximum: U.S. $2,000,000.00 (Filed With SEC on April 18, 2011)

SECURITY AGREEMENT (Filed With SEC on April 18, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 18, 2011)

COMMON STOCK PURCHASE WARRANT TAPIMMUNE, INC. (Filed With SEC on April 18, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 2, 2011)

SECURED CONVERTIBLE NOTE (Filed With SEC on March 2, 2011)

SECURITY AGREEMENT (Filed With SEC on March 2, 2011)

COMMON STOCK PURCHASE WARRANT TAPIMMUNE, INC. (Filed With SEC on March 2, 2011)

TECHNOLOGY OPTION AGREEMENT (Filed With SEC on June 4, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 18, 2010)

[FORM OF SENIOR SECURED CONVERTIBLE NOTE] (Filed With SEC on May 18, 2010)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 18, 2010)

[FORM OF SERIES A WARRANT] (Filed With SEC on May 18, 2010)

[FORM OF SERIES B WARRANT] (Filed With SEC on May 18, 2010)

[FORM OF SERIES C WARRANT] (Filed With SEC on May 18, 2010)

__________ (Filed With SEC on April 10, 2009)

SECURITY AGREEMENT TO THE SECURED LOANAGREEMENT Between the BORROWER and theLENDER Aggregate Principal Sum ofup to U.S.$175,000 (Filed With SEC on April 10, 2009)

__________ (Filed With SEC on April 10, 2009)

Category

Industry

Companies

Contracts

Marker Therapeutics, Inc. Contracts & Agreements